Understanding a gene linked to inherited eye diseases
Illuminating the function of CACNA2D4 in inherited retinal dystrophies
['FUNDING_R03'] · UNIVERSITY OF TEXAS AT AUSTIN · NIH-10896666
This study is looking at a gene called CACNA2D4 to better understand how it affects eye conditions like cone dystrophies and retinitis pigmentosa, with the hope of finding new treatments to help people with these inherited retinal disorders.
Quick facts
| Phase | ['FUNDING_R03'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS AT AUSTIN (nih funded) |
| Locations | 1 site (AUSTIN, UNITED STATES) |
| Trial ID | NIH-10896666 on ClinicalTrials.gov |
What this research studies
This research investigates the CACNA2D4 gene, which is associated with inherited retinal disorders like cone dystrophies and retinitis pigmentosa. By exploring how the a2d-4 protein functions in photoreceptors, the researchers aim to uncover the mechanisms that lead to these eye diseases. They will employ advanced techniques such as electrophysiology and optical imaging to study the gene's role in neurotransmitter release and its structural relationships. The findings could pave the way for new therapies targeting these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with inherited retinal dystrophies, particularly those linked to the CACNA2D4 gene.
Not a fit: Patients with retinal disorders not associated with the CACNA2D4 gene may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments for patients suffering from inherited retinal disorders.
How similar studies have performed: While the specific focus on CACNA2D4 is novel, similar research on ion channel proteins has shown promise in understanding and treating retinal disorders.
Where this research is happening
AUSTIN, UNITED STATES
- UNIVERSITY OF TEXAS AT AUSTIN — AUSTIN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEE, AMY — UNIVERSITY OF TEXAS AT AUSTIN
- Study coordinator: LEE, AMY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.